Kovitz Investment Group Partners’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$431K Buy
+8,855
New +$431K ﹤0.01% 1026
2021
Q2
Sell
-2,080
Closed -$253K 408
2021
Q1
$253K Buy
+2,080
New +$253K 0.01% 370